ClinicalTrials.Veeva

Menu
R

Revive Research Institute | Pulmonary Disease - Dr Syed T. Raza

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Astegolimab
Lorundrostat
Ensifentrine
glycopyrrolate
Povorcitinib

Parent organization

This site is a part of Revive Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to p...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Glycopyrrolate 21.25 mcg
Drug: Ensifentrine 3 mg

The primary purpose of the study is to assess the effect of lorundrostat taken orally (po) once a day on the Apnea-Hypopnea Index (AHI) in participan...

Active, not recruiting
Hypertension
Obstructive Sleep Apnea
Drug: Placebo
Drug: Lorundrostat

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Enrolling
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmo...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Astegolimab

Trial sponsors

G
Incyte logo
M
Roche logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems